Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Candel Therapeutics (CADL)

Candel Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CADL
DateTimeSourceHeadlineSymbolCompany
13/03/202520:45Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CADLCandel Therapeutics Inc
13/03/202520:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CADLCandel Therapeutics Inc
13/03/202520:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
13/03/202520:15GlobeNewswire Inc.Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsNASDAQ:CADLCandel Therapeutics Inc
25/02/202513:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
25/02/202513:00GlobeNewswire Inc.Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic CancerNASDAQ:CADLCandel Therapeutics Inc
14/02/202522:32Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CADLCandel Therapeutics Inc
14/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
14/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
14/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
14/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
17/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
17/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
17/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
17/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/01/202513:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/01/202513:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/01/202513:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/01/202513:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
13/01/202513:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
13/01/202513:00GlobeNewswire Inc.Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025NASDAQ:CADLCandel Therapeutics Inc
10/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
10/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
10/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
10/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
08/01/202513:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
08/01/202513:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
08/01/202513:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
08/01/202513:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
16/12/202421:01GlobeNewswire Inc.Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesNASDAQ:CADLCandel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CADL